The most widely used techniques for antigen loading of DCs vaccines are pulsing DCs with MHC-binding peptides of tumor-associated antigens (TAA), corresponding long peptides or proteins, TAA-encoding mRNA, or tumor lysate. The gene discussed is HLA-C; the disease is neoplasm.